RxDoctor Payments Data

Elinor Anan, MD

Physical Medicine & Rehabilitation · West Orange, NJNPI 1730177759

Payments from drug & device makers

$758in general payments, 2019–2025

Across 39 payments — averaging $19.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merz North America, Inc.$182
  • Azurity Pharmaceuticals, Inc.$64
  • Coloplast$60
  • Merz Pharmaceuticals, LLC$58
  • Argenx US, Inc.$54
  • Collegium Pharmaceutical, Inc.$42
  • plus $298 from 17 others

What the payments were for

  • Food & beverage$758100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$758 in reported general payments places this provider in the 70th percentile of 434 physical medicine & rehabilitation providers in New Jersey.

See all physical medicine & rehabilitation providers in New Jersey

Medicare billing

Part B allowed, 2024
$167,772
Medicare patients
286
Services billed
1,790

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban32$18,289
JardianceEmpagliflozin12$7,009
Lantus SolostarInsulin Glargine,hum.Rec.Anlog20$1,374
Nano 2nd Gen Pen NeedlePen Needle, Diabetic17$996
Gabapentin51$550
Atorvastatin Calcium71$392
Midodrine Hcl14$354
Pantoprazole Sodium52$253
Metoprolol Succinate26$196
Tamsulosin Hcl17$186
Levothyroxine Sodium21$128
Losartan Potassium22$125
Amlodipine Besylate30$116
Carvedilol18$115
Tramadol Hcl12$104

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$15$18,28932 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 434 physical medicine & rehabilitation providers in New Jersey.

Other physical medicine & rehabilitation in West Orange

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →